Hints and tips:
Related Special Reports
...Shares have declined 98 per cent from their 2021 highs to a little over $7 on Friday, giving it a market value of $674mn....
...At one point pharmaceutical company Pfizer even set out a “no jerks” policy....
...But, of course, there’s a reason why it’s widely called Shitibank; the sprawling, gormless Citi has for a v v v very long time proven adept at blithely ambling onto various rakes around the world....
...But the size of Pfizer and BioNTech’s amended deal still leaves little room for rivals in the EU, leaving the bloc largely dependent on one vaccine, according to health officials and analysts who believe...
...Despite a significant drop in biotech stocks over the past year, large pharmaceutical companies have shown little interest in picking up assets cheaply....
...At this stage, it appears things got a little bit spiteful: 55. Walkers argued and produced evidence that, in India, poppadoms may be made with potato in some regions....
...Details of a draft deal reported by the FT suggest that BioNTech/Pfizer could supply as many as 70mn doses a year until 2026, leaving little room for Novavax, Moderna or Sanofi....
...Given that close to three-quarters of the 224mn vaccine doses administered in Germany were produced by BioNTech in collaboration with Pfizer, the vast majority of the claims are being brought against the...
...its expertise in chemistry, to make a pill, and with Boston-based Alnylam Pharmaceuticals, to use its novel way of silencing genes, called RNA interference, to produce an injection that could be taken as little...
...He’s one of its early backers and current board chair, which makes things a little awkward when it comes to dealmaking....
...“We kind of cheer a little bit of volatility in the market,” says Day....
...“Scientists and researchers have worked to develop RSV vaccines with little success for over half a century....
...“It will be very difficult for Japan to achieve a V-shaped recovery in the number of new births,” he said, arguing that the most optimistic scenario might be maintaining the 2022 level or a little higher...
...Mr Talpins, a low-profile figure who charges some of the industry’s highest fees at his $16bn-in-assets fund, had until recently been betting stocks looked expensive and that there would be little positive...
...“The decision to allow the fourth vaccine to vulnerable populations is probably correct and it may give a little benefit — but not enough to support the decision to give it to all of the population,” she...
...But there has been little pushback by investors that have been richly rewarded for backing the companies....
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...There is little time to waste....
...The arts desk of FT Weekend is normally a happy little place. We are chatty. We are pally. We make each other cups of tea, laugh at each other’s bad puns....
...The median age of participants was 53, with little more than half in the 16 to 55 age group. More than a fifth were older than 65, a category more at risk from severe Covid....
...Reach out to me (imani.moise@ft.com) or Sid (sid.v@ft.com) to let us know. Happy reading!...
...“Children aren’t just little adults so, as we go into the younger ages [with vaccines], we are going to have to look at different doses . . . and so that’s what is probably taking a little bit longer to...
...Supply chain problems could make Christmas a little less cheerful for many British children, according to Gary Grant, founder and executive chair of The Entertainer, which operates more than 170 stores in...
...If Omicron evades existing vaccines, new versions could be ready in as little as 100 days. It is possible that the new variant will diminish, not demolish, the effectiveness of vaccines....
...“Even my closest friends knew only a little of it.”...
International Edition